Adams HR. Hemostatic and anticoagulant drugs. Veterinary pharmacology and therapeutics 5th edition. Ames, Iowa. EEUU: Ed.

Author:Shakanris Fejind
Language:English (Spanish)
Published (Last):9 September 2019
PDF File Size:9.79 Mb
ePub File Size:2.86 Mb
Price:Free* [*Free Regsitration Required]

Adams HR. Hemostatic and anticoagulant drugs. Veterinary pharmacology and therapeutics 5th edition. Ames, Iowa. EEUU: Ed. The Iowa State University Press, ; Prostaglandins, related factors and citoquines. En: Adams HR ed. Veterinary pharmacology and therapeutics 7th edition.

Performance characteristics and clinical evaluation of an in vitro bleeding time device—Thrombostat Thromb Res ; Vitamin K treatment of sweet clover poisoning in calves. J Am Vet Med Assoc ; An Real Acad Farm ; Coagulation studies: prothrombin time, partial thromboplastin time, bleeding time. Emerg Med Clin North Am ; Baggot JD. Pharmacokinetics: Disposition and fate of drugs in the body. En: Richard Adams ed. Veterinary pharmacology and therapeutics 7th Edition.

Iowa State University Press Flow cytometric assays to detect platelet activation and aggregation in device-implanted calves. J Biomed Mater Res ; Bankhead C. Inpharma ; Subcutaneous and intramuscular injection of oxytetracycline in calves: comparison of serum concentration and local tolerance. J Vet Pharmacol Therap ; Bascuas JA, Climent S. Tomo IV. Zaragoza: Ed. Facultad de Veterinaria de Zaragoza. Vet Res Commun ; J Vet Med A ; Activated coagulation time in cats: Normal revisited.

Chicago ; MexicoDF: Ed. Multicentre trial of ethamsylate for prevention of periventricular hemorrhage in very low birth-weight infants. Lancet ; Berkada B, Akokan G. Coloquio Internacional sobre acciones y efectos del Hemo Esteve. Laboratorios Dr. Esteve S. Reduction of blood loss and transfusion requirements after coronary artery bypass grafting: similar efficacy of tranexamic acid and aprotinin in aspirin-treated patients. J Card Surg ; Bhatt AD. Endotelins and anti-endotelins.

J Assoc Physicians India ; En: Medicina Veterinaria. Interamericana, ; Circulation ; Characterization of the normal bovine platelet aggregation response. Comp Biochem Physiol ;92C Bonnar J, Sheppard BL. Treatment of menorragia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid and tranexamic acid.

Br Med J ; Evaluation of the hemostatic function of stored platelet concentrates using the platelet function analyzer PFA TM.

Haematologica ; Bourdeaux MK. Platelets and coagulation. An update. Comparative pharmacokinetics of clortetracycline in milk fed versus conventionally fed calves. J Vet Pharmacol. Therap ;5: The Merck Index 11th Edition. Cailar J, Roquefeuil B. Callan MB, Giger U. Assessment of a point-of-care instrument for identification of primary hemostatic disorders in dogs.

Am J Vet Res ; Cameron A. Abciximab: real world outcomes and prescribing patterns. Canal P. Aggregation, release and desensitization induced in platelets from five species by platelet activating factor PAF. Thromb Haemostas ; Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.

J Thorac Cardiovasc Surg ; Hemostatic effects of aprotinin, tranexamic acid and epsilon-aminocaproic acid in primary cardiac surgery. Ann Thorac Surg ; A comparative study of ethamsylate and mefenamic acid in dysfunctional uterine bleeding. Br J Obstet Gynaecol ;98, Chanal JL. Epuration sanguine et elimination urinarie de la dicynone-carbone 14 chez le Lapin. Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease.

Chen JY. Ethamsylate in the prevention of Periventricular-Intraventricular Hemorrhage in premature Infants. J Formos Med Assoc ; Alterations in bovine platelet function and acute phase proteins induced by Pasteurella haemolytica A1. Can J Vet Res ; Local tolerance evaluation of intramuscular drug preparations. Il Farmaco ; Commission of The European Communities. Guidelines for the testing of veterinary medicinal products. Evaluation of the safety of veterinary Medicinal Products for the target animals.

En: The rules governing medicinal products in the European Community. Prophylactic ethamsylate for periventricular hemorrhage. Arch Dis Child ; Cornet J.

Ars Medici. High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results form TIMI Thrombolysis in Miocardial Infarction Couto G, Clinical approach to the bleeding dog or cat.


Etamsylate - Indications, Dosage, Side Effects and Precautions

Active principle: etamsylate Etamsylate mg. E , excipients q. By improving platelet adhesiveness and restoring capillary resistance, it reduces the bleeding time and blood losses. Etamsylate has no. Pharmacokinetics : When given p.


Dicynone 500 tablets Antihemorrhagic

It stimulates thrombopoiesis and their release from bone marrow. Haemostatic action is due to activation of thromboplastin formation on damaged sites of small blood vessels and decrease of PgI2 Prostacyclin I2 synthesis; it also facilitates platelet aggregation and adhesion , that at last induce decrease and stop of hemorrhage. It has been shown to reduce bleeding time and blood loss from wounds. This appears to relate to increased platelet aggregation mediated by a thromboxane A2 or prostaglandin F2a dependent mechanism. It has also been associated with decreased concentrations of 6-oxoprostaglandin F1a, a stable metabolite of prostacyclin.




Related Articles